A functional model for feline P-glycoprotein

J Vet Pharmacol Ther. 2016 Feb;39(1):95-7. doi: 10.1111/jvp.12248. Epub 2015 Jul 20.

Abstract

P-gp (ABCB1) belongs to the group of export transporters that is expressed in various species at biological barriers. Inhibition of P-gp can lead to changes in pharmacokinetics of drugs (drug-drug interactions), which can lead to toxicity and adverse side effects. This study aimed to establish a functional assay to measure the inhibitory potential of veterinary drugs on feline P-gp by means of fluorescence-associated flow cytometry of feline lymphoma cells. In this model, PSC833 and ivermectin potently inhibited P-gp function; cyclosporine and verapamil moderately inhibited P-gp function, whereas ketoconazole, itraconazole, diazepam, and its metabolites had no effect on P-gp function. This model can be used for testing the inhibitory potency of (new) drugs on feline P-gp.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / antagonists & inhibitors*
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism*
  • Animals
  • Cat Diseases / metabolism*
  • Cats
  • Cell Line, Tumor
  • Gene Expression Regulation / drug effects*
  • Lymphoma / metabolism
  • Lymphoma / veterinary*
  • Thymus Neoplasms / metabolism
  • Thymus Neoplasms / veterinary*

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1